32 related articles for article (PubMed ID: 7972805)
1. Evaluation of Advanced Nanomaterials for Cancer Diagnosis and Treatment.
Ndlovu NL; Mdlalose WB; Ntsendwana B; Moyo T
Pharmaceutics; 2024 Mar; 16(4):. PubMed ID: 38675134
[TBL] [Abstract][Full Text] [Related]
2. Towards clinically translatable
Park SM; Aalipour A; Vermesh O; Yu JH; Gambhir SS
Nat Rev Mater; 2017 May; 2(5):. PubMed ID: 29876137
[TBL] [Abstract][Full Text] [Related]
3. Synergistic enhancement of iron oxide nanoparticle and gadolinium for dual-contrast MRI.
Zhang F; Huang X; Qian C; Zhu L; Hida N; Niu G; Chen X
Biochem Biophys Res Commun; 2012 Sep; 425(4):886-91. PubMed ID: 22898051
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging of the liver: New imaging strategies for evaluating focal liver lesions.
Coenegrachts K
World J Radiol; 2009 Dec; 1(1):72-85. PubMed ID: 21160723
[TBL] [Abstract][Full Text] [Related]
5. Percentage of signal intensity loss for characterisation of focal liver lesions in patients with chronic liver disease using ferucarbotran-enhanced MRI.
Chou CT; Chen RC; Chen WT; Lii JM
Br J Radiol; 2010 Dec; 83(996):1023-8. PubMed ID: 20413445
[TBL] [Abstract][Full Text] [Related]
6. Comparison of MRI (including SS SE-EPI and SPIO-enhanced MRI) and FDG-PET/CT for the detection of colorectal liver metastases.
Coenegrachts K; De Geeter F; ter Beek L; Walgraeve N; Bipat S; Stoker J; Rigauts H
Eur Radiol; 2009 Feb; 19(2):370-9. PubMed ID: 18795299
[TBL] [Abstract][Full Text] [Related]
7. Distinguishing benign from malignant liver tumours.
Heiken JP
Cancer Imaging; 2007 Oct; 7 Spec No A(Special issue A):S1-14. PubMed ID: 17921080
[TBL] [Abstract][Full Text] [Related]
8. Ferucarbotran versus Gd-DTPA-enhanced MR imaging in the detection of focal hepatic lesions.
Cheng WZ; Zeng MS; Yan FH; Rao SX; Shen JZ; Chen CZ; Zhang SJ; Shi WB
World J Gastroenterol; 2007 Sep; 13(36):4891-6. PubMed ID: 17828821
[TBL] [Abstract][Full Text] [Related]
9. Detection of liver metastases: gadobenate dimeglumine-enhanced three-dimensional dynamic phases and one-hour delayed phase MR imaging versus superparamagnetic iron oxide-enhanced MR imaging.
Kim YK; Lee JM; Kim CS; Chung GH; Kim CY; Kim IH
Eur Radiol; 2005 Feb; 15(2):220-8. PubMed ID: 15624108
[TBL] [Abstract][Full Text] [Related]
10. Detection of hepatocellular carcinoma: comparison of ferumoxides-enhanced and gadolinium-enhanced dynamic three-dimensional volume interpolated breath-hold MR imaging.
Kwak HS; Lee JM; Kim YK; Lee YH; Kim CS
Eur Radiol; 2005 Jan; 15(1):140-7. PubMed ID: 15449000
[TBL] [Abstract][Full Text] [Related]
11. Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT.
Bartolozzi C; Donati F; Cioni D; Procacci C; Morana G; Chiesa A; Grazioli L; Cittadini G; Cittadini G; Giovagnoni A; Gandini G; Maass J; Lencioni R
Eur Radiol; 2004 Jan; 14(1):14-20. PubMed ID: 14730384
[TBL] [Abstract][Full Text] [Related]
12. Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions.
Kim YK; Lee JM; Kim CS
Eur Radiol; 2004 Jan; 14(1):5-13. PubMed ID: 14600778
[TBL] [Abstract][Full Text] [Related]
13. Enhancement characteristics of hepatic focal nodular hyperplasia and its scar by dynamic magnetic resonance imaging.
Martí-Bonmatí L; Casillas C; Dosdá R
MAGMA; 2000 Jul; 10(3):200-4. PubMed ID: 10873211
[TBL] [Abstract][Full Text] [Related]
14. Detection of colorectal liver metastases: prospective comparison of unenhanced and ferumoxides-enhanced magnetic resonance imaging at 1.5 T, dual-phase spiral CT, and spiral CT during arterial portography.
Lencioni R; Donati F; Cioni D; Paolicchi A; Cicorelli A; Bartolozzi C
MAGMA; 1998 Dec; 7(2):76-87. PubMed ID: 9951768
[TBL] [Abstract][Full Text] [Related]
15. Hepatic tumors: detection and characterization at 1-T MR imaging enhanced with AMI-25.
Denys A; Arrive L; Servois V; Dubray B; Najmark D; Sibert A; Menu Y
Radiology; 1994 Dec; 193(3):665-9. PubMed ID: 7972805
[TBL] [Abstract][Full Text] [Related]
16. Superparamagnetic iron oxide--enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions.
Vogl TJ; Hammerstingl R; Schwarz W; Mack MG; Müller PK; Pegios W; Keck H; Eibl-Eibesfeldt A; Hoelzl J; Woessmer B; Bergman C; Felix R
Radiology; 1996 Mar; 198(3):881-7. PubMed ID: 8628887
[TBL] [Abstract][Full Text] [Related]
17. [Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media].
Di Cesare E; Cariello G; Barile A; Sabatini M; Michelini O; Erriquez D; Masciocchi C
Radiol Med; 2000 Oct; 100(4):245-50. PubMed ID: 11155451
[TBL] [Abstract][Full Text] [Related]
18. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227).
Saini S; Edelman RR; Sharma P; Li W; Mayo-Smith W; Slater GJ; Eisenberg PJ; Hahn PF
AJR Am J Roentgenol; 1995 May; 164(5):1147-52. PubMed ID: 7717222
[TBL] [Abstract][Full Text] [Related]
19. MR imaging of hepatic metastases.
Pedro MS; Semelka RC; Braga L
Magn Reson Imaging Clin N Am; 2002 Feb; 10(1):15-29. PubMed ID: 11998572
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
